Researchers of the University of Barcelona (UB) have analyzed, with massive sequencing techniques for the first time, the evolution of the hepatitis A virus with samples from patients. The results, published in the journal EBioMedicine, show the presence of variants of the virus that could escape the effects of the vaccine. The study, led by the Research Group on Enteric Viruses of the UB, in collaboration with Vall d'Hebron Research Institute (VHIR) and the Public Health Agency of Barcelona (ASPB), can have implications in the vaccination policies against the disease.
The article counts on the participation of the lecturers Aurora SabriÃ , Albert Bosch, Susana Guix and Rosa Maria PintÃ³, from the Department of Genetics, Microbiology and Statistics of the Faculty of Biology of the UB.
Hepatitis A is a liver inflammation caused by a virus. Its symptomatology is quite light and can disappear after the first weeks, but in some cases the disease can last for months. Among the most affected groups are men who have risky sexual behaviours with other men (MSM).
This study analyzed samples from MSM patients, both vaccinated and non-vaccinated, who caught the virus during an outbreak of hepatitis A in Barcelona (2016-2018). The objective was to study the evolution of the virus and check whether there are emerging variants that can escape the effects of the vaccine. "We identified antigenic variants in vaccinated and non-vaccinated patients, but only the former increase in number, which suggests the positive selection," says PintÃ³.
The appearance of the hepatitis A virus antigenic variants could become a threat to public health and could have consequences in the future uses of the current available vaccines. "If we select a variant which escapes the vaccine, this one would stop being effective. The study shows that, in cases such as the occurred one due the lack of vaccines, this can happen," notes the researcher.
In some countries, controlling recent outbreaks of hepatitis A has been blocked by the low coverage of vaccination and lack of vaccines, which made administrations apply restrictions in the doses.
During the outbreak, these restrictions affected especially people in the MSM group. "If a few doses of vaccination are given, or if the common doses were given long ago, or the vaccine is given to patients who caught the virus weeks ago, those variants of the virus that avoid the effects of the vaccine can be selected. This is especially relevant in the MSM group, since the virus dose through risky sexual practises is very high, and circulating antibodies are not enough to neutralize the inoculum or the first produced viruses," says PintÃ³.
In this sense, researchers recommend giving two doses of the vaccine and, in some situations stated in the publication, they suggest giving additional booster doses.
Apart from specifying the vaccination protocol, the expert states they should "work in order to have easier-to-get vaccines so there are no vaccine shortages and doses do not have to be reduced."
Source: University of Barcelona